Japan Industry Frets Blockbuster Price Slash Proposals
This article was originally published in PharmAsia News
Executive Summary
In a flurry of regulatory activity before the major year-end holidays, Japan has finalized proposals for its next set of drug reimbursement reforms due to be implemented next April, which include potentially huge price cuts for blockbuster products that have the innovative industry worried.